SIALORRHEA
Clinical trials for SIALORRHEA explained in plain language.
Never miss a new study
Get alerted when new SIALORRHEA trials appear
Sign up with your email to follow new studies for SIALORRHEA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drooling treatment shows promise in Year-Long study
Symptom relief CompletedThis study tested a medication called MYOBLOC for adults who have troublesome drooling (sialorrhea) due to conditions like Parkinson's disease, stroke, or ALS. Over one year, 187 participants received repeated injections to see if it safely reduces drooling. The main goal was to …
Matched conditions: SIALORRHEA
Phase: PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief
Last updated May 26, 2026 12:09 UTC
-
Drooling treatment shows promise in Late-Stage trial
Symptom relief CompletedThis study tested an injected medication called MYOBLOC to reduce troublesome drooling in 187 adults. Drooling can be a side effect of many health conditions. The treatment was injected directly into the salivary glands and was shown to safely decrease saliva production. The goal…
Matched conditions: SIALORRHEA
Phase: PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC